FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Au Financiers IPO and Eris Lifesciences IPO.
Au Financiers IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Eris Lifesciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Au Financiers IPO | Eris Lifesciences IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Citigroup Global Markets India Private Limited Hdfc Bank Limited ICICI Securities Limited Motilal Oswal Investment Advisors Limited |
Axis Capital Limited Citigroup Global Markets India Private Limited Credit Suisse Securities (India) Private Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Au Financiers IPO is up to ₹1,912.51 Cr whereas the issue size of the Eris Lifesciences IPO is up to ₹1,741.16 Cr. The final issue price of Au Financiers IPO is ₹358.00 per share and of Eris Lifesciences IPO is ₹603.00 per share.
Au Financiers IPO | Eris Lifesciences IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ₹355.00 per share | ₹600.00 per share |
Issue Price (Upper) | ₹358.00 per share | ₹603.00 per share |
Issue Price (Final) | ₹358.00 per share | ₹603.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹60.00 per share | |
Market Lot Size | 41 shares | 24 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | ||
OFS Issue Size | 5,34,22,169 shares | 2,88,75,000 shares |
OFS Issue Size (Amount) | ||
Issue Size Total | 2,88,75,000 shares | |
Issue Size Total (Amount) | up to ₹1,912.51 Cr | up to ₹1,741.16 Cr |
Au Financiers IPO opens on Jun 28, 2017, while Eris Lifesciences IPO opens on Jun 16, 2017. The closing date of Au Financiers IPO and Eris Lifesciences IPO is Jun 30, 2017, and Jun 20, 2017, respectively.
Au Financiers IPO | Eris Lifesciences IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jun 28, 2017 | Jun 16, 2017 |
Issue Close | Jun 30, 2017 | Jun 20, 2017 |
Basis Of Allotment (Tentative) | Jul 05, 2017 | Jun 23, 2017 |
Initiation of Refunds (Tentative) | Jul 06, 2017 | Jun 27, 2017 |
Credit of Share (Tentative) | Jul 07, 2017 | Jun 28, 2017 |
Listing date (Tentative) | Jul 10, 2017 | Jun 29, 2017 |
Anchor Lockin End date 1 | Aug 04, 2017 | Jul 23, 2017 |
Anchor Lockin End date 2 | Oct 03, 2017 | Sep 21, 2017 |
Au Financiers IPO P/E ratio is , as compared to Eris Lifesciences IPO P/E ratio of .
Au Financiers IPO | Eris Lifesciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Au Financiers IPO retail investors (RII) are offered 1,83,47,760 shares while in Eris Lifesciences IPO retail investors are offered 1,83,47,760 shares. Qualified institutional buyers (QIB) are offered 1,04,84,434 shares in Au Financiers IPO and 86,17,500 shares in Eris Lifesciences IPO.
Au Financiers IPO | Eris Lifesciences IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 1,04,84,434 shares | 86,17,500 shares |
NII | 78,63,326 shares | 43,08,750 shares |
RII | 1,83,47,760 shares | 28,72,500 shares |
Employee | 10,00,000 shares | 1,50,000 shares |
Others | ||
Total | 3,76,95,520 shares | 1,59,48,750 shares |
Au Financiers IPO subscribed 53.60x in total, whereas Eris Lifesciences IPO subscribed 3.29x.
Au Financiers IPO | Eris Lifesciences IPO | |
---|---|---|
QIB (times) | 78.77x | 4.68x |
NII (times) | 143.51x | 0.45x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.52x | 3.51x |
Employee (times) | 1.45x | 0.86x |
Other (times) | ||
Total (times) | 53.60x | 3.29x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|